KING, B., TEMPERTON, N., GREHAN, K., SCOTT, S., WRIGHT, E., TARR, A.W. and DALY, J.M., 2016. Technical considerations for the generation of novel pseudotyped viruses: Future Virology Future Virology. In press, URBANOWICZ, R. A., MCCLURE, C.P., BROWN, R.J.P, TSOERIDIS, T., PERSSON, M.A.A., KREY, T., IRVING, W., BALL, J.K. and TARR, A.W., 2016. A diverse panel of Hepatitis C Virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance: Journal of Virology J Virol. In press, FERNS, R. B., TARR, A. W., HUE, S., URBANOWICZ, R. A., MCCLURE, C. P., GILSON, R., BALL, J. K., NASTOULI, E., GARSON, J. A. and PILLAY, D., 2016. Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals: Virology Virology. 492, 213-24 2016. Flexible and rapid construction of viral chimeras applied to Hepatitis C Virus. The Journal of general virology. (In Press.) FERNS RB, TARR AW, HUE S, URBANOWICZ RA, MCCLURE CP, GILSON R, BALL JK, NASTOULI E, GARSON JA and PILLAY D, 2016. Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. Virology. 492, 213-24 2016. Novel functional hepatitis C virus glycoprotein isolates identified using an optimised viral pseudotype entry assay. The Journal of general virology. (In Press.) MASON, CHRISTOPHER P. and TARR, ALEXANDER W., 2015. Human Lectins and Their Roles in Viral Infections MOLECULES. 20(2), 2229-2271 TARR, ALEXANDER W., KHERA, TANVI, HUEGING, KATHRIN, SHELDON, JULIE, STEINMANN, EIKE, PIETSCHMANN, THOMAS and BROWN, RICHARD J. P., 2015. Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design VIRUSES-BASEL. 7(7), 3995-4046 MEOLA, ANNALISA, TARR, ALEXANDER W., ENGLAND, PATRICK, MEREDITH, LUKE W., MCCLURE, C. PATRICK, FOUNG, STEVEN K. H., MCKEATING, JANE A., BALL, JONATHAN K., REY, FELIX A. and KREY, THOMAS, 2015. Structural Flexibility of a Conserved Antigenic Region in Hepatitis C Virus Glycoprotein E2 Recognized by Broadly Neutralizing Antibodies JOURNAL OF VIROLOGY. 89(4), 2170-2181 HAKAMI, ABDULRAHIM R., BALL, JONATHAN K. and TARR, ALEXANDER W., 2015. Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces JOURNAL OF VIROLOGICAL METHODS. 221, 1-8 KING, BARNABAS, TEMPERTON, NIGEL J., GREHAN, KEITH, SCOTT, SIMON D., WRIGHT, EDWARD, TARR, ALEXANDER W. and DALY, JANET M., 2015. Technical considerations for the generation of novel pseudotyped viruses: Future Virology Future Virology. 11(1), 47-59 URBANOWICZ RA, MCCLURE CP, BROWN RJ, TSOLERIDIS T, PERSSON MA, KREY T, IRVING WL, BALL JK and TARR AW, 2015. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance. Journal of virology. 90(7), 3288-301 BALL JK, TARR AW and MCKEATING JA, 2014. The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral research. (In Press.) NG PP, KUO C, WANG S, EINAV S, ARCAINI L, PAULLI M, PORTLOCK CS, MARCOTRIGIANO J, TARR A, BALL J, LEVY R and LEVY S, 2014. B cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins. Blood. (In Press.) KIM YC, TARR AW and PENFOLD CN, 2014. Colicin import into E. coli cells: A model system for insights into import mechanisms of bacteriocins. Biochimica et biophysica acta. (In Press.) MEREDITH LW, FARQUHAR MJ, TARR AW and MCKEATING JA, 2014. Type I interferon rapidly restricts infectious hepatitis C virus particle genesis. Hepatology (Baltimore, Md.). (In Press.) HAMED MR, BROWN RJP, ZOTHNER C, URBANOWICZ RA, MASON CP, KRARUP A, MCCLURE CP, IRVING WL, BALL JK, HARRIS M, HICKLING TP and TARR AW, 2014. Recombinant human L-ficolin directly neutralizes hepatitis C virus entry. Journal of innate immunity. 6(5), 676-84 MEOLA A, TARR AW, ENGLAND P, MEREDITH LW, MCCLURE CP, FOUNG SKH, MCKEATING JA, BALL JK, REY FA and KREY T, 2014. Structural Flexibility of a Conserved Broadly Neutralizing Epitope in Hepatitis C Virus Glycoprotein E2. Journal of virology. (In Press.) LACEK K, URBANOWICZ RA, TROISE F, DE LORENZO C, SEVERINO V, DI MARO A, TARR AW, FERRARA F, PLOSS A, TEMPERTON N, BALL JK, NICOSIA A, CORTESE R and PESSI A, 2014. Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation. The Journal of biological chemistry. 289(50), 35015-28 KIM, YOUNG CHAN, TARR, ALEXANDER W. and PENFOLD, CHRISTOPHER N., 2014. Colicin import into E. coli cells: A model system for insights into the import mechanisms of bacteriocins BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 1843(8), 1717-1731 TARR, A.W., LAFAYE, P., MEREDITH, L., DAMIER-PIOLLE, L., URBANOWICZ, R.A., MEOLA, A., JESTIN, J.-L., BROWN, R.J.P., MCKEATING, J.A., REY, F.A., BALL, J.K. and KREY, T., 2013. An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission Hepatology. 58(3), 932-939 SAUTTO G, TARR AW, MANCINI N and CLEMENTI M, 2013. Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies. Clinical & developmental immunology. 2013, 450963 BROWN, R.J.P., KOUTSOUDAKIS, G., URBANOWICZ, R.A., MIRZA, D., GINKEL, C., RIEBESEHL, N., CALLAND, N., ALBECKA, A., PRICE, L., HUDSON, N., DESCAMPS, V., BACKX, M., MCCLURE, C.P., DUVERLIE, G., PECHEUR, E., DUBUISSON, J., PEREZ-DEL-PULGAR, S., FORNS, X., STEINMANN, E., TARR, A.W., PIETSCHMANN, T. and BALL, J.K., 2013. Analysis of serine codon conservation reveals diverse phenotypic constraints on Hepatitis C Virus glycoprotein evolution Journal of Virology. n/a(n/a), n/a ROBERTS APE, DOIDGE R, TARR AW and JOPLING CL, 2013. The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122. Nucleic acids research. (In Press.) EDWARDS VC, TARR AW, URBANOWICZ RA and BALL JK, 2012. The role of neutralizing antibodies in hepatitis C virus infection. The Journal of general virology. 93(Pt 1), 1-19